Hemagglutinin-Influenza A Virus H3N2 New York 55/04 (Recombinant)

Recombinant Hemagglutinin-Influenza A Virus H3N2 New York/55/04 (H2N2 New York)

Source: Baculovirus Insect Cells.

Background: H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteins on the surface of its coat, hemagglutinin (H) and neuraminidase (N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2 by antigenic shift, in which fenes from multiple subtypes re-assorted to form a new virus. Both the H2N2 and H3N2 strains contained genes from avian influenza viruses.

Description: Recombinant full length H3N2/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 70,000 dalton.

Physical appearance: Sterile filtered colorless solution.

Formulation: The recombinant H3N2 A/New York/55/04 solution contains 30mM sodium phosphate, pH 7.4 and 500mM NaCl.

Stability: H3N2/New York/55/04 recombinant should be stored at 4°C

Immunological activity: western blot- 0.1μg - 1μg per strip; ELISA- 1μg/well.

Purity: Greater than 90.0% as determined by SDS-PAGE

Usage: BioWORLD's products are furnished for LABORATORY RESEARCH USE ONLY. THe product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.